News & Events
The webinar will feature a presentation by Parkinson’s Disease (PD) Key Opinion Leaders Robert Hauser, MD, MBA and C. Warren Olanow, MD, along with Sheila Oren, MD, MBA Pharma Two B CEO, to discuss the recently announced positive results from the pivotal Phase III Study of P2B001 in early Parkinson’s disease. This will be followed by a company update.
The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.
Each year, the MDS International Congress attracts delegates from around the world who come to learn about the latest research and perspectives, to listen to world renowned speakers, and to be exposed to the most up-to-date information in the field of Movement Disorders.